Education
About Us
Working with TipRanks
Follow Us
Star Combo Pharma Ltd. (AU:S66)
ASX:S66
S66 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.11 - AU$0.23
Previous CloseN/A
Volume100.00K
Average Volume (3M)1.95K
Market Cap
AU$21.60M
Enterprise ValueAU$11.71M
Total Cash (Recent Filing)AU$4.62M
Total Debt (Recent Filing)AU$57.86K
Price to Earnings (P/E)24.2
Beta-0.48
Next Earnings
Aug 26, 2025EPS EstimateN/A
Last Dividend Ex-Date
Oct 14, 2024Dividend Yield2.31%
Share Statistics
EPS (TTM)<0.01
Shares Outstanding135,002,980
10 Day Avg. Volume630
30 Day Avg. Volume1,951
Financial Highlights & Ratios
PEG Ratio0.29
Price to Book (P/B)N/A
Price to Sales (P/S)0.74
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Star Combo Pharma Ltd. News
PremiumCompany Announcements
Star Combo Pharma Gains Strong Shareholder Support
PremiumCompany Announcements
Star Combo Pharma Highlights Growth at 2024 AGMPremiumCompany Announcements
Star Combo Pharma Unveils Corporate Governance AchievementsPremiumCompany Announcements
Star Combo Pharma Strengthens Governance and DiversityPremiumCompany Announcements
Star Combo Pharma Announces 2024 AGM and Key Director Re-elections
PremiumCompany Announcements
Star Combo Pharma Expands into Gummy Market---
S66 FAQ
What was Star Combo Pharma Ltd.’s price range in the past 12 months?
Star Combo Pharma Ltd. lowest share price was AU$0.10 and its highest was AU$0.23 in the past 12 months.
What is Star Combo Pharma Ltd.’s market cap?
Star Combo Pharma Ltd.’s market cap is AU$21.60M.
When is Star Combo Pharma Ltd.’s upcoming earnings report date?
Star Combo Pharma Ltd.’s upcoming earnings report date is Aug 26, 2025 which is in 147 days.
How were Star Combo Pharma Ltd.’s earnings last quarter?
Star Combo Pharma Ltd. released its earnings results on Feb 26, 2025. The company reported AU$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by AU$0.002.
Is Star Combo Pharma Ltd. overvalued?
According to Wall Street analysts Star Combo Pharma Ltd.’s price is currently Overvalued.
Does Star Combo Pharma Ltd. pay dividends?
Star Combo Pharma Ltd. pays a Notavailable dividend of AU$0.003 which represents an annual dividend yield of 2.31%. See more information on Star Combo Pharma Ltd. dividends here
What is Star Combo Pharma Ltd.’s EPS estimate?
Star Combo Pharma Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Star Combo Pharma Ltd. have?
Star Combo Pharma Ltd. has 135,002,980 shares outstanding.
What happened to Star Combo Pharma Ltd.’s price movement after its last earnings report?
Star Combo Pharma Ltd. reported an EPS of AU$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -11.111%.
Which hedge fund is a major shareholder of Star Combo Pharma Ltd.?
Currently, no hedge funds are holding shares in AU:S66
---
Star Combo Pharma Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
42.85%
12-Months-Change
Fundamentals
Return on Equity
2.68%
Trailing 12-Months
Asset Growth
5.70%
Trailing 12-Months
Company Description
Star Combo Pharma Ltd.
Star Combo Pharma Limited engages in the manufacturing and distribution of health food products and nutritional supplements in Australia and China. The company operates in two segments, Star Combo and Austoyou Retail. It develops, manufactures, markets, and sells natural health supplements and skin care products. The company provides its products through e-commerce platform to Chinese health product consumers; and two retail stores in Sydney. Star Combo Pharma Limited was founded in 2004 and is based in Smithfield, Australia.
---
Technical Analysis
---